Recent news on Winrho

Cangene's VIG (Vaccinia Immune Globulin Intravenous) Approved by ...  -  25 May 2007
PharmaLive.com (press release),Cangene manufactures VIG in its Winnipeg manufacturing facility using a process similar to that used for WinRho(R) SDF and the Company's other products that

FDA Approves Cangene's HepaGam B for Liver Transplant Recipients  -  Apr 9, 2007
eMaxHealth.com,Cangene manufactures HepaGam B in its Winnipeg facility using a process similar to that of WinRho(R) SDF, Vaccinia Immune Globulin and VariZIG,

Nabi Biopharmaceuticals Announces Fourth Quarter and Full-Year ...  -  Apr 3, 2007
Drug Newswire (press release),Revenues in 2005 included $6.2 million of sales of WinRho SDF(R) [Rho (D) Immune Globulin Intravenous (Human)] which the company stopped selling during 2005

Cangene Reports Results for 2nd Quarter of Fiscal 2007  -  Mar 16, 2007
PharmaLive.com (press release),Stronger WinRho(R) SDF sales in the US partially offset a decline in product sales for the period. R&D services revenues also declined, as activity on US

Cangene reports results for second quarter of fiscal 2006  -  Mar 16, 2007
PharmaLive.com (press release),Revenue for the quarter was up due to sales of Vaccinia immune globulin (VIG) to the UK, which more than offset reduced WinRho(R) SDF sales in the US that

S. Fla. biotec firm trims loss  -  Mar 12, 2007
Bradenton Herald,Revenue for the year was $89.9 million, down from $94.1 million in 2005, a drop caused by the company stopping the sale of WinRho SDF, an immune globulin.

Cangene shares lower after second-quarter profits slashed in half ...  -  Mar 16, 2007
Canada.com,However, stronger American sales of the company's WinRho, used to treat blood disorders in newborns, partially offset the decline in product sales,

Cangene's HepaGam Added To Novation's Product Listing  -  Mar 15, 2007
HULIQ,Cangene manufactures HepaGam B(TM) in its Winnipeg facility using a process similar to that of WinRho(R) SDF and Vaccinia immune globulin, the Company's

Nabi Biopharmaceuticals Announces Fourth Quarter and Full-Year ...  -  Mar 13, 2007
PharmaLive.com (press release),Revenues in 2005 included $6.2 million of sales of WinRho SDF(R) [Rho (D) Immune Globulin Intravenous (Human)] which the company stopped selling during 2005

Florida HIV/AIDS Infusion Clinic President Arrested for Allegedly ...  -  Jan 17, 2007
Kaiser network.org,According to the affidavit in support of the arrest warrant, the case involved high amounts of WinRho billing done in the names of Victor and Delsa Ferran,

State Arrests Miami Doctor For Allegedly Using Aids Clinic To ...  -  Jan 13, 2007
All Headline NewsMPCU investigators said the billings submitted to both programs were for quantities of WinRho more than one hundred times larger than the average WinRho

Miami HIV/AIDS clinic president charged with Medicaid fraud  -  Jan 12, 2007
Bradenton Herald,The billings Rivera allegedly submitted to both programs were for quantities of WinRho more than 100 times larger than the average WinRho prescription.

HIV/AIDS clinic owner is charged with fraud  -  Jan 12, 2007
Miami Herald,The billing involved unusually high amounts of WinRho, an AIDS/HIV treatment medication. AIDS fraud in Florida is thought by law enforcement officials to be

New products, contracts will boost Cangene's growth, chief ...  -  Dec 12, 2006
Canada.com,..."This, coupled with our existing solid base, supported by our still-growing WinRho SDF franchise and existing portfolio of other approved products,

Cangene Reports Results for First Quarter of Fiscal 2007; Earnings ...  -  Dec 12, 2006
PharmaLive.com (press release),WinRho(R) SDF sales in the US strengthened and royalty revenue increased; however, these increases were largely offset by decreased research revenues,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional